Differentiation between autism and schizophrenia in the screening phase. Pilot-research.

Differentiation between autism and schizophrenia in the screening phase. Pilot-research. - Differentiation between autism and schizophrenia in the screening phase

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32100

Enrollment

Registered

2008-06-05

Start date

2008-04-16

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autism and schizphrenia

Interventions

zie Nederlandse tekst

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - male - age between 18 and 65 - normal or high verbal intelligence - diagnosis schizophrenia or high functioning autism - a comorbid psychiatric desease may not be prominent

Exclusion criteria

Exclusion criteria: see D4a

Design outcomes

Primary

Measure	Time frame
To test hypothesis 1 the mean sumscores per instrument, per group will be calculated for both versions of the VIS-V and the AQ. The mean total scores of the two groups for both versions of the VIS-V and the AQ will be compared to each other with T-tests. These tests are used to determine the equality of the mean scores of the two independent groups. To test hypothesis 2 the meanscores of the subscales of the VIS-V and the AQ for both groups will be compared with T-tests. These tests are used to determine the equality of the mean scores of the two independent groups.	—

Measure

Time frame

To test hypothesis 1 the mean sumscores per instrument, per group will be calculated for both versions of the VIS-V and the AQ. The mean total scores of the two groups for both versions of the VIS-V and the AQ will be compared to each other with T-tests. These tests are used to determine the equality of the mean scores of the two independent groups. To test hypothesis 2 the meanscores of the subscales of the VIS-V and the AQ for both groups will be compared with T-tests. These tests are used to determine the equality of the mean scores of the two independent groups.

—

Secondary

Measure	Time frame
To test hypothesis 3 the interference of negative symptomatology with the hight of the scores on the VIS-V and AQ questionnaire is measured with a liniair regressionanalysis.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)